Synaptosomal Mitochondrial Dysfunction in 5xFAD Mouse Model of Alzheimer's Disease

Abstract

Brain mitochondrial dysfunction is hallmark pathology of Alzheimer’s disease (AD). Recently, the role of synaptosomal mitochondrial dysfunction in the development of synaptic injury in AD has received increasing attention. Synaptosomal mitochondria are a subgroup of neuronal mitochondria specifically locating at synapses. They play an essential role in fueling synaptic functions by providing energy on the site; and their defects may lead to synaptic failure, which is an early and pronounced pathology in AD. In our previous studies we have determined early synaptosomal mitochondrial dysfunction in an AD animal model (J20 line) overexpressing human Amyloid beta (Aβ), the key mediator of AD. In view of the limitations of J20 line mice in representing the full aspects of amyloidopathy in AD cases, we employed 5xFAD mice which are thought to be a desirable paradigm of amyloidopathy as seen in AD subjects. In addition, we have also examined the status of synaptosomal mitochondrial dynamics as well as Parkin-mediated mitophagy which have not been previously investigated in this mouse model. In comparison to nontransgenic (nonTg mice), 5xFAD mice demonstrated prominent synaptosomal mitochondrial dysfunction. Moreover, synaptosomal mitochondria from the AD mouse model displayed imbalanced mitochondrial dynamics towards fission along with activated Parkin and LC3BII recruitment correlating to spatial learning & memory impairments in 5xFAD mice in an age-dependent manner. These results suggest that synaptosomal mitochondrial deficits are primary pathology in Aβ-rich environments and further confirm the relevance of synaptosomal mitochondrial deficits to the development of AD.

The Close Interconnection between Mitochondrial Dynamics and Mitophagy in Cancer

“…In fact, K-ras-induced lung tumors require mitophagy to sustain mitochondrial function and lipid catabolism and, in this case, inhibition of mitophagy leads to proliferative arrest, so negatively altering the tumor fate (104). In addition, a recent study indicates that AMPK confers metabolic stress resistance on leukemia-initiating cells and promotes leukemogenesis by suppressing ROS production and maintenance of metabolism (105), this probably also through mitophagy activation.…”

New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders

“…These observations correlated with memory impairment. Synaptosomal mitochondria had a reduced respiratory control ratio and state III respiration, with reduced ATP production [22]. These findings are important, because mitochondria localized to synaptosomes are critical to neuronal function and signal transduction.…”

Facilitation of brain mitochondrial activity by 5-aminolevulinic acid in a mouse model of Alzheimer's disease

“…9, 10 These observations suggest that prevention of mitochondrial deterioration could slow neurodegeneration in the early or prodromal phase of AD. Thus, supplementation with 5-ALA could be an effective means of preserving or increasing mitochondrial activity in the brains of aged individuals.…”

“…The precipitated fraction was suspended in storage buffer (10 USA), and anti-NR2B (BD Biosciences) antibodies were purchased from the indicated suppliers.…”

“…. 10 This dysfunction was remarkable in that it was specific to mitochondria in synaptosomes, rather than all mitochondria in the brain.…”